Arcturus Therapeutics
ARCT
#9100
Rank
โ‚ฌ0.14 B
Marketcap
5,20ย โ‚ฌ
Share price
-1.00%
Change (1 day)
-55.77%
Change (1 year)

Revenue for Arcturus Therapeutics (ARCT)

Revenue in 2026 (TTM): โ‚ฌ36 Million

According to Arcturus Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ37.11 Million. In 2025 the company made a revenue of โ‚ฌ57.22 Million a decrease over the revenue in the year 2024 that were of โ‚ฌ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Arcturus Therapeutics from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ36 M-37.08%
2025 โ‚ฌ57.22 M-56.97%
2024 โ‚ฌ0.13 B-6.81%
2023 โ‚ฌ0.14 B-25.61%
2022 โ‚ฌ0.19 B1657.68%
2021 โ‚ฌ10.91 M40.72%
2020 โ‚ฌ7.75 M-58.21%
2019 โ‚ฌ18.55 M34.77%
2018 โ‚ฌ13.77 M-17.62%
2017 โ‚ฌ16.71 M
2016 N/A
2015 N/A
2014 N/A
2013 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas
NRC Health
NRC
โ‚ฌ0.12 B 227.34%๐Ÿ‡บ๐Ÿ‡ธ USA